Correlation Between Inozyme Pharma and Exelixis
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Exelixis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Exelixis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Exelixis, you can compare the effects of market volatilities on Inozyme Pharma and Exelixis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Exelixis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Exelixis.
Diversification Opportunities for Inozyme Pharma and Exelixis
-0.83 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Inozyme and Exelixis is -0.83. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Exelixis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exelixis and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Exelixis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exelixis has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Exelixis go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Exelixis
Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Exelixis. In addition to that, Inozyme Pharma is 1.13 times more volatile than Exelixis. It trades about -0.79 of its total potential returns per unit of risk. Exelixis is currently generating about 0.33 per unit of volatility. If you would invest 2,832 in Exelixis on August 24, 2024 and sell it today you would earn a total of 651.00 from holding Exelixis or generate 22.99% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Inozyme Pharma vs. Exelixis
Performance |
Timeline |
Inozyme Pharma |
Exelixis |
Inozyme Pharma and Exelixis Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Inozyme Pharma and Exelixis
The main advantage of trading using opposite Inozyme Pharma and Exelixis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Exelixis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exelixis will offset losses from the drop in Exelixis' long position.Inozyme Pharma vs. ZyVersa Therapeutics | Inozyme Pharma vs. Sonnet Biotherapeutics Holdings | Inozyme Pharma vs. Zura Bio Limited | Inozyme Pharma vs. Phio Pharmaceuticals Corp |
Exelixis vs. TG Therapeutics | Exelixis vs. Viking Therapeutics | Exelixis vs. Madrigal Pharmaceuticals | Exelixis vs. BioXcel Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |